Taihill Venture
VC Fund
Boston, United States
Taihill Venture is a VC fund in Boston focused on Biotechnology and Artificial Intelligence. Early-stage, sector agnostic deep tech fund investing in disruptive and impactful companies.
- Total investments:
- 70
- Last investment:
- Lead investor:
- 4%
- Fund size:
- $10M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Taihill Venture invests in
Stages Taihill Venture invests in
Countries Taihill Venture invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Hongkai He
|
|||
Fawaz Alshawwa
|
|||
Tianmeng Xu
|
|||
1 more contact available
Investment Focus
Industry
- Biotechnology 17 (24%)
- Artificial Intelligence 15 (21%)
- Health Care 13 (19%)
- Medical 9 (13%)
- FinTech 7 (10%)
Stage
- Seed 27 (39%)
- Series A 13 (19%)
- Pre-Seed 10 (14%)
- Venture - Series Unknown 6 (9%)
- Angel 3 (4%)
Country
- United States 47 (67%)
- China 6 (9%)
- Canada 3 (4%)
- United Kingdom 1 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Hongkai He
Founding Partner
|
Founding Partner | Total investments: 1 | Find email | |
|
Fawaz Alshawwa
Venture Partner
|
Venture Partner | Total investments: 0 | Find email | |
Sky Yu
Founding Partner
|
Founding Partner | Total investments: 0 | Find email | |
|
Tianmeng Xu
Founding Partner
|
Founding Partner | Total investments: 4 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Collov Labs
|
Collov is a virtual interior design & shopping platform that offers interior design services stocked with shoppable goods from many brands. | $23M / Series A / Apr 21, 2026 | |
Fortitude Biomedicines
|
Fortitude Biomedicines is a biotechnology company that develops antibody-based biologic drugs targeting autoimmune diseases. | $13M / Seed / Jan 26, 2026 | |
|
Fengluan Education
|
Fengluan Education focused on developing AI-powered and interactive learning products for school-age students (primarily K-12) | $1.4M / Angel / Dec 31, 2025 | |
Shouxing Technology
|
Shouxing Technology develops humanoid robots that integrate AI, robotics, and biomimetic design to simulate human behavior and interaction. The company builds full-stack systems that integrate software and hardware, enabling robots to perceive environments, process multimodal inputs, and respond with coordinated speech, facial expressions, and bodymovement. Its product portfolio includes humanoid robot platforms and core components such as micro-actuators designed for precise facial motion and expressive capabilities.The company focuses on emotional interaction systems that interpret voice, visual cues, and context to generate lifelike responses, supporting applications in service, education, and human-facing environments. Its technology incorporates large language and vision-language models alongside self-supervised learning to enable adaptive communication and autonomous learning. Shouxing Technology also develops customizable robotic characters and digital-human integrations that extend human-robot interaction beyond functional tasks into social engagement. | $14M / Series A / Sep 29, 2025 | |
Foundry BioSciences
|
Foundry BioSciences is a biotechnology company at the forefront of integrating artificial intelligence (AI) with protein engineering to address challenges in longevity science and extend human healthspan. The company is dedicated to developing advanced protein language models using deep learning, | Pre-Seed / Jul 02, 2025 | |
Komiko
|
We are a startup based in the Bay Area founded by Stanford student. At Entropia, we’re building AI creation tools and a social community for anime fans. Backed by top-tier investors, we’ve secured multi-million-dollar funding to fuel our vision. | $3.4M / Seed / Dec 10, 2024 | |
BluWhale
|
BluWhale's mission is to leverage AI and ML to allow game developers to focus on ways to improve the game rather than wrangling and making sense of astronomical amounts of data. BluWhale's smart automation will do the heavy lifting usually reserved for data analysts and data scientists all in the background, and surface actionable insight | Series A / Oct 30, 2024 | |
|
Shouxing Technology
|
Shouxing Technology develops humanoid robots that integrate AI, robotics, and biomimetic design to simulate human behavior and interaction. The company builds full-stack systems that integrate software and hardware, enabling robots to perceive environments, process multimodal inputs, and respond with coordinated speech, facial expressions, and bodymovement. Its product portfolio includes humanoid robot platforms and core components such as micro-actuators designed for precise facial motion and expressive capabilities.The company focuses on emotional interaction systems that interpret voice, visual cues, and context to generate lifelike responses, supporting applications in service, education, and human-facing environments. Its technology incorporates large language and vision-language models alongside self-supervised learning to enable adaptive communication and autonomous learning. Shouxing Technology also develops customizable robotic characters and digital-human integrations that extend human-robot interaction beyond functional tasks into social engagement. | Angel / Oct 01, 2024 | |
Bot Auto
|
Bot Auto develops and operates autonomous trucks for middle-mile freight. | $20M / Seed / Sep 26, 2024 | |
Kano Therapeutics
|
Kano Therapeutics focuses on the correction of gene-length DNA using circular single-stranded DNA biomaterials. The company provides a comprehensive platform that combines manufacturing, application, and computational tools for genetic payload development. This approach empowers researchers and organizations to advance genetic cures effectively andsafely. | $5M / Seed / Aug 12, 2024 | |
| See all 70 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Taihill Venture invest in?
Taihill Venture invests primarily in Biotechnology, Artificial Intelligence and Health Care startups, most often at Seed and Series A stage. Most of the 70 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Taihill Venture?
Public channels for Taihill Venture include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Taihill Venture?
The team at Taihill Venture includes Hongkai He (Founding Partner), Fawaz Alshawwa (Venture Partner) and Sky Yu (Founding Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
